Patent US4156729A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4156729A Expired / Lapsed US ⏱️ 0.0 years remaining

1,2-Benzisothiazolin-3-ones

Assignee: Bayer AG
•
Filing: 1977-01-19
•
Granted: 1979-05-29
•
Expires: 1997-01-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 6-Substituted-1,2-benzisothiazolin-3-ones carrying an aminoalkyl group in the 2-position and being optionally substituted in the 4- and/or 5-position are antithrombotic agents. The compounds, of which 2-(2-diethylaminoethyl)-4,5-dimethyl-1,2-benzisothiazolin-3-one is a representative embodiment, can be prepared by cyclization of an appropriately substituted bis-[2-(aminoalkylcarbamyl)phenyl]disulfide, or by other disclosed methods.

Inventors

  • 👤 Horst Boshagen
  • 👤 Ulrich Horlein
  • 👤 Karl-August Meng, deceased
  • 👤 Friedel Seuter

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 15:01
CPC Classifications
C; C07; C07D; C07D275/00; C07D275/04; A; A61; A61P; A61P7/00; A61P7/02; C07C; C07C323/00; C07D417/00; C07D417/02; C07D417/06

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 180 words
A compound selected from the group consisting of 6-substituted 7-unsubstituted 1,2-benzisothiazolin-3-ones depicted by the formula: ##STR48## and the pharmaceutically acceptable acid addition salts thereof wherein R 1 when taken independently of R 2 is chloro, bromo, fluoro, nitro, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or an aromatic substituent selected from the group consisting of phenoxy, benzyloxy and phenylthio which aromatic substituent is unsubstituted or nonsubstituted with alkyl of 1 to 4 carbon atoms or halo; R 2 when taken independently of R 1 is hydrogen, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; R 1 and R 2 taken together are trimethylene, tetramethylene or pentamethylene; R 3 is hydrogen, halo, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; each of R 4 and R 5 is alkyl of 1 to 4 carbon atoms; and A is alkylene of 2 to 5 carbon atoms, alkylenoxyalkyl of 4 to 8 carbon atoms or alkylenethioalkyl of 4 to 8 carbon atoms.
Claim 2
Dependent Claim 180 words
A compound selected from the group consisting of 6-substituted 7-unsubstituted 1,2-benzisothiazolin-3-ones depicted by the formula: ##STR48## and the pharmaceutically acceptable acid addition salts thereof wherein R 1 when taken independently of R 2 is chloro, bromo, fluoro, nitro, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or an aromatic substituent selected from the group consisting of phenoxy, benzyloxy and phenylthio which aromatic substituent is unsubstituted or nonsubstituted with alkyl of 1 to 4 carbon atoms or halo; R 2 when taken independently of R 1 is hydrogen, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; R 1 and R 2 taken together are trimethylene, tetramethylene or pentamethylene; R 3 is hydrogen, halo, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; each of R 4 and R 5 is alkyl of 1 to 4 carbon atoms; and A is alkylene of 2 to 5 carbon atoms, alkylenoxyalkyl of 4 to 8 carbon atoms or alkylenethioalkyl of 4 to 8 carbon atoms.
Claim 3
Dependent Claim 39 words
A compound according to claim 1 wherein R 1 taken independently of R 2 is chloro, nitro, methyl, methoxy, ethoxy, butoxy, phenoxy, benzyloxy, phenylthio or chlorophenylthio; R 2 is hydrogen or methoxy; and R 3 is hydrogen or methyl.
Claim 4
Dependent Claim 28 words
A compound according to claim 2 wherein A is ethylene, trimethylene, tetramethylene, 1-methyltetramethylene, ethylenoxyethyl or ethylenethioethyl; and each of R 4 and R 5 is methyl or ethyl.
Claim 5
Dependent Claim 40 words
A compound according to claim 1 wherein R 1 is chloro or methyl; R 2 is hydrogen; R 3 is hydrogen or methyl; A is ethylene or trimethylene and each of R 4 and R 5 is methyl or ethyl.
Claim 6
Dependent Claim 11 words
A compound according to claim 1 wherein said 1,2-benzisothiazolin-3-one is 2-(3-dimethylaminopropyl)-6-chloro-1,2-benzisothiazolin-3-one.
Claim 7
Dependent Claim 11 words
A compound according to claim 1 wherein said 1,2-benzisothiazolin-3-one is 2-(2-diethylaminoethyl)-6-chloro-1,2-benzisothiazolin-3-one.
Claim 8
Dependent Claim 11 words
A compound according to claim 1 wherein said 1,2-benzisothiazolin-3-one is 2-(2-diethylaminoethyl)-4,6-dimethyl-1,2-benzisothiazolin-3-one.
Claim 9
Dependent Claim 11 words
A compound according to claim 1 wherein said 1,2-benzisothiazolin-3-one is 2-(3-diethylaminopropyl)-4,6-dimethyl-1,2-benzisothiazolin-3-one.
Claim 10
Dependent Claim 11 words
A compound according to claim 1 wherein said 1,2-benzisothiazolin-3-one is 2-(3-dimethylaminopropyl)-4,6-dimethyl-1,2-benzisothiazolin-3-one.
Claim 11
Dependent Claim 63 words
A compound according to claim 1 which is a salt of said 1,2-benzoisothiazolin-3-one with an acid selected from the group consisting of oxalic acid, 1,5-naphthalenedisulfonic acid, hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid, methanesulphonic acid, acetic acid, tartaric acid, lactic acid, succinic acid, citric acid, malic acid, maleic acid, sorbic acid, aconitic acid, salicyclic acid, phthalic acid, embonic acid, and enanthic acid.
Claim 12
Dependent Claim 35 words
The method of achieving an antithrombotic effect in a human or other warm blooded animal in need thereof which consists essentially of administering thereto an antithrombotically effective amount of a compound according to claim 1.
Claim 13
Dependent Claim 24 words
A pharmaceutical composition consisting essentially of an antithrombotically effective amount of a compound according to claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 14
Dependent Claim 44 words
A compound according to claim 1 wherein R 1 is halo, alkyl of 1 to 4 carbon atoms or alkoxy of 1 to 4 carbon atoms; R 2 is hydrogen; and R 3 is hydrogen, halo or alkyl of 1 to 4 carbon atoms.

References Cited (Backward Citations)

US3227715A Cited
US4113728A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-05-28 1982-11-27 1983-05-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-05-28 1986-11-27 1987-05-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-05-28 1990-11-27 1991-05-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag